Gilead Sciences (GILD) Non-Current Deferred Tax Liability (2012 - 2026)
Gilead Sciences (GILD) posted Non-Current Deferred Tax Liability of $333 million for Q2 2026, down 48.9% from $652 million a year earlier and down 15.1% from the prior quarter.
Powered by 
Analysis
Gilead Sciences (GILD) Non-Current Deferred Tax Liability (2012 - 2026) Analysis & Trends
At the end of FY2025, Gilead Sciences' Non-Current Deferred Tax Liability came in at $402 million, down 44.5% from FY2024.
- Annual Non-Current Deferred Tax Liability has declined for four consecutive years, with a five-year compound annual growth rate of -36.6% (FY2020 to FY2025).
- In prior years, Gilead Sciences' Non-Current Deferred Tax Liability was $724 million in FY2024 (-54.4%), $1.59 billion in FY2023 (-40.6%), $2.67 billion in FY2022 (-38.6%) and $4.36 billion in FY2021 (+11.3%).
- The Q2 2026 figure stands as the lowest quarterly Non-Current Deferred Tax Liability since Q3 2015.
- On a year-over-year basis, Non-Current Deferred Tax Liability has declined in each of the last 18 quarters, with an average decline of 41.2% over the last eight quarters.
- The strongest year-over-year quarter for Non-Current Deferred Tax Liability in the past five years was Q4 2021, with growth of 11.3%; the weakest was Q1 2024, with a decline of 61.1%.
- According to Business Quant data, Non-Current Deferred Tax Liability for the three prior quarters was $392 million (Q1 2026), $402 million (Q4 2025) and $597 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Bristol Myers Squibb | 127.55 Bn | 78.82 Bn | 9.25 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 333.00 Mn |
| Mar 31, 2026 | 392.00 Mn |
| Dec 31, 2025 | 402.00 Mn |
| Sep 30, 2025 | 597.00 Mn |
| Jun 30, 2025 | 652.00 Mn |
| Mar 31, 2025 | 709.00 Mn |
| Dec 31, 2024 | 724.00 Mn |
| Sep 30, 2024 | 794.00 Mn |
| Jun 30, 2024 | 907.00 Mn |
| Mar 31, 2024 | 933.00 Mn |
| Dec 31, 2023 | 1.59 Bn |
| Sep 30, 2023 | 1.98 Bn |
| Jun 30, 2023 | 2.11 Bn |
| Mar 31, 2023 | 2.40 Bn |
| Dec 31, 2022 | 2.67 Bn |
| Sep 30, 2022 | 3.04 Bn |
| Jun 30, 2022 | 3.36 Bn |
| Mar 31, 2022 | 3.69 Bn |
| Dec 31, 2021 | 4.36 Bn |
| Sep 30, 2021 | 4.60 Bn |
API Access
Gilead Sciences Non-Current Deferred Tax Liability API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deferred-tax-liability", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();